日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2024/05/21 | 21 : 02 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:ALAR | Alarum Technologies Ltd |
2024/05/21 | 21 : 02 | GlobeNewswire Inc. | Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults | NASDAQ:ARDX | Ardelyx Inc |
2024/05/21 | 21 : 02 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:GBX | Greenbrier Companies Inc |
2024/05/21 | 21 : 02 | GlobeNewswire Inc. | Hill International Names Andrew Barwick as Senior Vice President, Saudi Arabia | | |
2024/05/21 | 21 : 02 | PR Newswire (Canada) | North American Rail Solutions Acquires Strategic Rail, LLC in Tomahawk, WI | | |
2024/05/21 | 21 : 02 | PR Newswire (Canada) | North American Rail Solutions acquiert Strategic Rail, LLC à Tomahawk, dans le Wisconsin | | |
2024/05/21 | 21 : 02 | PR Newswire (US) | North American Rail Solutions Acquires Strategic Rail, LLC in Tomahawk, WI | | |
2024/05/21 | 21 : 01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:LWAY | Lifeway Foods Inc |
2024/05/21 | 21 : 01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:LWAY | Lifeway Foods Inc |
2024/05/21 | 21 : 01 | GlobeNewswire Inc. | Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK | | |
2024/05/21 | 21 : 01 | PR Newswire (US) | MARS ANNOUNCES PARTNERSHIP WITH TRIPADVISOR, CONNECTING TODAY'S PET PARENTS WITH BETTER TRAVEL EXPERIENCES | | |
2024/05/21 | 21 : 01 | PR Newswire (US) | Matt Mowan Joins Jones Birdsong Insurance Services, a Division of Specialty Program Group LLC, as Vice President of Motorsports Insurance | | |
2024/05/21 | 21 : 01 | PR Newswire (US) | First Supply Partners with Exotec to Boost its Operational Capabilities and Support Business Growth | | |
2024/05/21 | 21 : 01 | PR Newswire (Canada) | MARS ANNOUNCES PARTNERSHIP WITH TRIPADVISOR, CONNECTING TODAY'S PET PARENTS WITH BETTER TRAVEL EXPERIENCES | | |
2024/05/21 | 21 : 01 | PR Newswire (US) | MARS ANNOUNCES PARTNERSHIP WITH TRIPADVISOR, CONNECTING TODAY'S PET PARENTS WITH BETTER TRAVEL EXPERIENCES | | |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:IGXT | IntelGenx Technologies Corporation (QB) |
2024/05/21 | 21 : 00 | GlobeNewswire Inc. | An upgraded network to deliver next generation multi-gig internet service | | |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:ACIU | AC Immune SA |
2024/05/21 | 21 : 00 | GlobeNewswire Inc. | KANZHUN LIMITED Announces Board Changes | NASDAQ:BZ | Kanzhun Ltd |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:CW | Curtiss Wright Corp |
2024/05/21 | 21 : 00 | GlobeNewswire Inc. | Alarum Announces Q1 2024 Results | NASDAQ:ALAR | Alarum Technologies Ltd |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ABCB | Ameris Bancorp |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:VIST | Vista Energy SAB de CV |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:SPNS | Sapiens International Corporation NV |
2024/05/21 | 21 : 00 | GlobeNewswire Inc. | Allegro MicroSystems Expands Isolated Gate Driver Portfolio with Power-Thru Combo Chip | NASDAQ:ALGM | Allegro MicroSystems Inc |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:CBDW | 1606 Corporation (PK) |
2024/05/21 | 21 : 00 | GlobeNewswire Inc. | Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK | NASDAQ:ALVO | Alvontech |
2024/05/21 | 21 : 00 | GlobeNewswire Inc. | Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK | NYSE:RDY | Dr Reddys Laboratories Ltd |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form SC 14D9 - Solicitation, recommendation statements | NYSE:NYC | American Strategic Investment Co |
2024/05/21 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:NVMI | Nova Ltd |